Voronoi, Inc. (KOSDAQ:310210)

South Korea flag South Korea · Delayed Price · Currency is KRW
296,500
-3,000 (-1.00%)
Apr 29, 2026, 10:10 AM KST
168.08%
Market Cap 5.39T
Revenue (ttm) 7.51B
Net Income (ttm) -42.71B
Shares Out 18.00M
EPS (ttm) -2,374.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 32,247
Average Volume 109,033
Open 299,500
Previous Close 299,500
Day's Range 296,500 - 308,500
52-Week Range 89,800 - 375,500
Beta 1.76
RSI 49.53
Earnings Date May 8, 2026

About Voronoi

Voronoi, Inc. researches, develops, and discovers small molecule kinase inhibitors in South Korea. Its products pipeline includes VRN01, an oral leucine rich repeat kinase 2 inhibitor targeting glioblastoma multiforme to treat brain and pancreatic cancers; VRN07, VRN06, and VRN11 for the treatment of lung cancer; VRN08 and VRN10 to treat breast cancer; and VRN02 for the treatment of rheumatoid arthritis and atopic dermatitis. The company’s products pipeline also comprise VRN04-1 to treat autoimmune diseases; VRN04-2 for the treatment of multipl... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 140
Stock Exchange KOSDAQ
Ticker Symbol 310210
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.